ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 920

Patient Preferences for the Development of a Mobile Health (mHealth) Application (App) for Systemic Lupus Erythematosus (SLE) Patients: A Qualitative Study

Alana B. Levine1, Adena Batterman2, VP Bykerk1, Aislinn Crank3, Su Jin Kim4, Juliette Kleinman5, Laura Leuenberger1, Laura Robbins6, Jillian A. Rose3, Jane E. Salmon1,3, Nadine Spring1, My-Lan Tran7 and Roberta Horton2, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Social Work Programs, Hospital for Special Surgery, New York, NY, 3Hospital for Special Surgery, New York, NY, 4School of Social Work, Columbia University, New York, NY, 5Patient Care & Quality, Hospital for Special Surgery, New York, NY, 6Education & Academic Affairs, Hospital for Special Surgery, New York, NY, 7Department of Social Work Programs, Hospital for Special Surgery, New York City, NY

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: MHealth, qualitative and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Health Services Research I: Digital Health and Patient, Provider Factors in Rheumatic Disease

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: SLE patients face many challenges due to lupus, including pain, fatigue, managing medications and appointments, and emotional impact. Patients employ various strategies to manage these challenges. mHealth offers the opportunity to improve self-management and self-efficacy and could prove effective in helping SLE patients manage their disease. Patient input is critical to the development of an SLE-specific mHealth tool; our aim was to explore patient preferences and interest related to development of an mHealth app for SLE patients.

Methods: Subjects ≥15 years old who met ACR SLE criteria were recruited from a diverse patient population at a large, urban SLE referral center. A standardized focus group methodology was developed by an expert panel of rheumatologists and social workers. Focus group sessions, moderated by clinical social workers trained in this methodology, were audio recorded, transcribed, and analyzed using NVivo in an iterative process to develop thematic categories. Questions explored challenges due to SLE, current coping strategies, how an SLE app could help with disease self-management, app format and design, and priorities for app content.

Results: 57 subjects participated in 8 focus groups. Participants were mostly female (84%), well-educated (68% had at least some college education), and 46% self-identified as belonging to a minority group. Mean SLEDAI was 3.7 (range 0-10) and mean SLICC-DI was 1.3 (range 0-7). Subjects identified physical manifestations (pain, fatigue, hair loss, change in weight), emotional/psychological issues (stress, frustration, unpredictability of disease, depression), and medications (adherence issues, pill burden) as current challenges in managing lupus; scheduling, exercise, sleep, relaxation, and social networking helped to manage those challenges. Regarding how the app could help, six key themes emerged (Table): 1) track symptoms, 2) manage medications, 3) manage appointments, 4) communicate with providers, 5) nutrition and exercise tips, and 6) manage emotional/psychological issues. Ease of use, simplicity, and customizability were deemed critical to uptake of the app; finger pain, Raynaud’s, denial/avoidance of illness, and technological complexity were identified as potential deterrents to use. 98% of participants said they would use an app to help manage lupus.

Conclusion: Participants were overwhelmingly interested in an mHeatlh app designed to help manage SLE and identified challenges an app could help them manage. These patient-generated themes can be used in platform development and assessment of a lupus-specific mHealth app.

How an App Can Help:   Emerging Themes

Selected Illustrative   Quotes

1.  Track   symptoms

[You could record]   symptoms for the day, because sometimes when I go to the doctor I don’t   remember certain symptoms I had during the month and if I have a place to   write that down, like how I was feeling certain days, I think it would help.

2.  Manage   medications

It would be great if   you could put in your meds and your doses and time of day and it alerted you   like, “Okay, it’s time to take something.”    And then also… we’d get to the doctor and they say, “What have you   been taking?”  It’s like, there.

3.  Manage   appointments

There are many   different aspects of planning…The appointment reminder might be two days   before the appointment, because I find that if I don’t write it down, I will   forget… I need time to process a day or two before.

4. Communicate   with providers

Sometimes when we’re   at the appointment, we sometimes forget what was wrong at that moment, so   when [the doctors] ask us a question, we’re just like, “Oh, no, no,   everything is fine…” and then you leave and remember, “Ok, I should have said   this and I should have said that!”

5.  Nutrition   and exercise recommendations

So…we see what we’re   getting in terms of diet and what we’re eating, how it affects the symptoms,   that could be helpful, and it would help everybody.

6.  Resources   to manage emotional/psychological issues

The initial   diagnosis can be very traumatic and I think if you have an app that can guide   you through processing those emotions as well as learning how to accept help   and communicating effectively what the illness does to you, I think it would   be a helpful app.

 


Disclosure: A. B. Levine, None; A. Batterman, None; V. Bykerk, None; A. Crank, None; S. J. Kim, None; J. Kleinman, None; L. Leuenberger, None; L. Robbins, None; J. A. Rose, None; J. E. Salmon, None; N. Spring, None; M. L. Tran, None; R. Horton, None.

To cite this abstract in AMA style:

Levine AB, Batterman A, Bykerk V, Crank A, Kim SJ, Kleinman J, Leuenberger L, Robbins L, Rose JA, Salmon JE, Spring N, Tran ML, Horton R. Patient Preferences for the Development of a Mobile Health (mHealth) Application (App) for Systemic Lupus Erythematosus (SLE) Patients: A Qualitative Study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/patient-preferences-for-the-development-of-a-mobile-health-mhealth-application-app-for-systemic-lupus-erythematosus-sle-patients-a-qualitative-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-preferences-for-the-development-of-a-mobile-health-mhealth-application-app-for-systemic-lupus-erythematosus-sle-patients-a-qualitative-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology